HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies.
Steichen, J.M., Kulp, D.W., Tokatlian, T., Escolano, A., Dosenovic, P., Stanfield, R.L., McCoy, L.E., Ozorowski, G., Hu, X., Kalyuzhniy, O., Briney, B., Schiffner, T., Garces, F., Freund, N.T., Gitlin, A.D., Menis, S., Georgeson, E., Kubitz, M., Adachi, Y., Jones, M., Mutafyan, A.A., Yun, D.S., Mayer, C.T., Ward, A.B., Burton, D.R., Wilson, I.A., Irvine, D.J., Nussenzweig, M.C., Schief, W.R.
Immunity
